Xybion provides digital frameworks for highly regulated business processes primarily in the health sciences market. Its software is deployed at the FDA and also several major drug developers & producers. Xybion’s software replaced legacy paper-based approval processes with integrated digital systems for trial enrollment, results and approvals with the FDA at Pfizer, Moderna & J&J for the COVID-19 vaccines. As a result, Xybion was one of the underlying digital systems that helped to accelerate the development and approval of the life-saving COVID-19 vaccines globally.
Building upon this success in life sciences, Xybion is poised to expand dramatically over the next several years by becoming a proven digital transformation engine for highly regulated business processes. Building upon its base of approximately C$23M of annual revenue, contracted revenue, backlog, and the current sales pipeline combine to imply organic growth potential for the next few years of between 20% and 25% per annum. The company is already profitable and cash-flow positive.
Head of Quality Assurance
Heidi leads Xybion’s Quality Assurance practice. She has over 20 years’ experience in designing and implementing quality assurance policies. Since joining Xybion in 2000, Heidi worked with several clients to design quality policies and ensure compliance. She is responsible to hosting Xybion customer audits. Heidi has a BA degree in Biology from The King’s College.